TabletAnti Diabetic

Pioglitazone + Glimepiride + Metformin

Pioglitazone + Glimepiride + Metformin Hydrochloride · Thiazolidinedione, sulfonylurea and biguanide antidiabetic combination

TabletAnti Diabetic

Pioglitazone + Glimepiride + MetforminProspero Healthcare

These tablets combine pioglitazone, glimepiride and metformin, three antidiabetic agents with different mechanisms. They are used to improve glycaemic control in adults with type 2 diabetes who need combination therapy.

Uses

Type 2 diabetes mellitus

Enquire about this product

Specifications are indicative; availability, composition, pack sizes and registration requirements may vary by destination market.

01Specification

Product details

Composition: Pioglitazone + Glimepiride + Metformin Hydrochloride
Available strengthsIndicative: 15 mg + 1 mg + 500 mg · 15 mg + 2 mg + 500 mg
Dosage form: Tablet
Therapeutic category: Anti Diabetic
Therapeutic class: Thiazolidinedione, sulfonylurea and biguanide antidiabetic combination
Packing: 10 × 10 tablets in blister / Alu-Alu strips
Storage: Store below 30 °C, protected from light and moisture.

02Related

From the same category

View the category